Latest on Clinical Research
Latest on Preclinical Research, AI in Healthcare and everything else!
PLEASE: check your SPAM folder from time to time. Newsletters tend to be classified as spam 🙁
Want to stay in the loop without the hassle of hunting down updates? Subscribe to my newsletter! You’ll get the latest blog posts delivered straight to your inbox, no digging required. There’s no set schedule for my updates (life is a little unpredictable!), but I aim to share something new with you at least once a week!
If you want to read the past newsletters, please click here or on Newsletters in the main menu.
Donations
I am now accepting financial contributions to help support two key efforts. First, I’ll soon need to cover the cost of the newsletter delivery system (Kit.com). Second, I’m eager to continue developing the Navigator Project—an intuitive tool designed to simplify prostate cancer trial research by filtering results based on a range of parameters. It will be fast, user-friendly, and straightforward (at least, that’s the goal!).
You will be redirected to https://prostatewarriors.kit.com/products/jar
Phase 3 Trial Evaluates Rezvilutamide vs Enzalutamide in mHSPC
/in Clinical Trial, Metastatic, Phase 3/by MaxPhase 2 Trial For a New Triplet Therapy: SHR3680 (Rezvilutamide), HS-20093 and SHR2554
/in Clinical Trial, Metastatic, Phase 2/by MaxPhase 1 Trial for RAD 402, Terbium Based Radioligand for Metastatic or Locally Advanced or Prostate Cancer
/in Clinical Trial, Metastatic, Non-Metastatic, Phase 1, Phase 1/by Max